Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717

被引：0
|
作者：
R. E. Hampson
R. A. España
G. A. Rogers
L. J. Porrino
S. A. Deadwyler
机构：
[1] Wake Forest University Health Sciences,Department of Physiology and Pharmacology
[2] Medical School of the Americas,undefined
来源：
Psychopharmacology | 2009年 / 202卷
关键词：
Hippocampus; Prefrontal cortex; Striatum; AMPA receptor; NMDA receptor; Macaque; Temporal lobe; PET; Behavior; Calcium imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：355 / 369
页数：14
相关论文
共 32 条
  • [1] Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717
    Hampson, R. E.
    Espana, R. A.
    Rogers, G. A.
    Porrino, L. J.
    Deadwyler, S. A.
    [J]. PSYCHOPHARMACOLOGY, 2009, 202 (1-3) : 355 - 369
  • [2] Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates
    Porrino, LJ
    Daunais, JB
    Rogers, GA
    Hampson, RE
    Deadwyler, SA
    [J]. PLOS BIOLOGY, 2005, 3 (09): : 1639 - 1652
  • [3] Effects of the Putative Cognitive-Enhancing Ampakine, CX717, on Attention and Object Recognition Memory
    Zheng, Yiwen
    Balabhadrapatruni, Sangeeta
    Masumura, Chisako
    Darlington, Cynthia L.
    Smith, Paul F.
    [J]. CURRENT ALZHEIMER RESEARCH, 2011, 8 (08) : 876 - 882
  • [4] Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep
    Boyle, Julia
    Stanley, Neil
    James, Lynette M.
    Wright, Nicola
    Johnsen, Sigurd
    Arbon, Emma L.
    Dijk, Derk-Jan
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (08) : 1047 - 1057
  • [5] Molecular and synaptic mechanisms underlying cognitive malfunction and cognitive enhancement
    Knafo, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S25 - S26
  • [6] A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia
    Donald C Goff
    J Steven Lamberti
    Andrew C Leon
    Michael F Green
    Alexander L Miller
    Jayendra Patel
    Theo Manschreck
    Oliver Freudenreich
    Steven A Johnson
    [J]. Neuropsychopharmacology, 2008, 33 : 465 - 472
  • [7] A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
    Goff, Donald C.
    Lamberti, J. Steven
    Leon, Andrew C.
    Green, Michael F.
    Miller, Alexander L.
    Patel, Jayendra
    Manschreck, Theo
    Freudenreich, Oliver
    Johnson, Steven A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2008, 33 (03) : 465 - 472
  • [8] Neuroplastic Mechanisms Underlying Perceptual and Cognitive Enhancement
    de Villers-Sidani, Etienne
    Mishra, Jyoti
    Zhou, Xiaoming
    Voss, Patrice
    [J]. NEURAL PLASTICITY, 2016, 2016
  • [9] Cognitive mechanisms underlying achievement deficits in children with mathematical learning disability
    Geary, David C.
    Hoard, Mary K.
    Byrd-Craven, Jennifer
    Nugent, Lara
    Numtee, Chattavee
    [J]. CHILD DEVELOPMENT, 2007, 78 (04) : 1343 - 1359
  • [10] Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1
    Costa, RM
    Silva, AJ
    [J]. JOURNAL OF CHILD NEUROLOGY, 2002, 17 (08) : 622 - 626
1234